230 related articles for article (PubMed ID: 33879260)
1. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial.
Hser YI; Ober AJ; Dopp AR; Lin C; Osterhage KP; Clingan SE; Mooney LJ; Curtis ME; Marsch LA; McLeman B; Hichborn E; Lester LS; Baldwin LM; Liu Y; Jacobs P; Saxon AJ
Addict Sci Clin Pract; 2021 Apr; 16(1):24. PubMed ID: 33879260
[TBL] [Abstract][Full Text] [Related]
2. Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics.
Ober AJ; Dopp AR; Clingan SE; Curtis ME; Lin C; Calhoun S; Larkins S; Black M; Hanano M; Osterhage KP; Baldwin LM; Saxon AJ; Hichborn EG; Marsch LA; Mooney LJ; Hser YI
J Subst Use Addict Treat; 2024 Jan; 156():209194. PubMed ID: 37863356
[TBL] [Abstract][Full Text] [Related]
3. Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single-arm, multisite feasibility study.
Hser YI; Mooney LJ; Baldwin LM; Ober A; Marsch LA; Sherman S; Matthews A; Clingan S; Fei Z; Zhu Y; Dopp A; Curtis ME; Osterhage KP; Hichborn EG; Lin C; Black M; Calhoun S; Holtzer CC; Nesin N; Bouchard D; Ledgerwood M; Gehring MA; Liu Y; Ha NA; Murphy SM; Hanano M; Saxon AJ
J Rural Health; 2023 Sep; 39(4):780-788. PubMed ID: 37074350
[TBL] [Abstract][Full Text] [Related]
4. Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.
Weintraub E; Seneviratne C; Anane J; Coble K; Magidson J; Kattakuzhy S; Greenblatt A; Welsh C; Pappas A; Ross TL; Belcher AM
JAMA Netw Open; 2021 Aug; 4(8):e2118487. PubMed ID: 34448869
[TBL] [Abstract][Full Text] [Related]
5. Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
Nunes EV; Levin FR; Reilly MP; El-Bassel N
J Subst Abuse Treat; 2021 Mar; 122():108196. PubMed ID: 33221125
[TBL] [Abstract][Full Text] [Related]
6. An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic.
Hughes PM; Verrastro G; Fusco CW; Wilson CG; Ostrach B
J Rural Health; 2021 Jun; 37(3):467-472. PubMed ID: 33720447
[TBL] [Abstract][Full Text] [Related]
7. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
[TBL] [Abstract][Full Text] [Related]
8. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
[TBL] [Abstract][Full Text] [Related]
9. Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.
Bart GB; Saxon A; Fiellin DA; McNeely J; Muench JP; Shanahan CW; Huntley K; Gore-Langton RE
Addict Sci Clin Pract; 2020 Jan; 15(1):4. PubMed ID: 31948487
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and treating incarcerated populations for opioid use disorder.
Donelan CJ; Hayes E; Potee RA; Schwartz L; Evans EA
J Subst Abuse Treat; 2021 May; 124():108216. PubMed ID: 33288348
[TBL] [Abstract][Full Text] [Related]
11. Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19.
Poulsen MN; Santoro W; Scotti R; Henderson C; Ruddy M; Colistra A
J Addict Med; 2023 Mar-Apr 01; 17(2):e110-e118. PubMed ID: 36129690
[TBL] [Abstract][Full Text] [Related]
12. The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: a cross-sectional study.
Saunders EC; Satcher MF; Monico LB; McDonald RD; Springer SA; Farabee D; Gryczynski J; Nyaku A; Reeves D; Kunkel LE; Schultheis AM; Schwartz RP; Lee JD; Marsch LA; Waddell EN
Health Justice; 2022 Dec; 10(1):35. PubMed ID: 36529829
[TBL] [Abstract][Full Text] [Related]
13. Social Determinants of Health and Continuity of Medications for Opioid Use Disorder Among Patients Receiving Treatment in Rural Primary Care Settings.
Pham H; Ober A; Baldwin LM; Mooney LJ; Zhu Y; Fei Z; Hser YI
J Addict Med; 2024 May-Jun 01; 18(3):331-334. PubMed ID: 38315721
[TBL] [Abstract][Full Text] [Related]
14. Co-Constructing a Community-Based Telemedicine Program for People With Opioid Use Disorder During the COVID-19 Pandemic: Lessons Learned and Implications for Future Service Delivery.
Høj SB; de Montigny C; Chougar S; Léandre R; Beauchemin-Nadeau MÈ; Boyer-Legault G; Goyette A; Lamont SK; Bruneau J
JMIR Public Health Surveill; 2023 Jul; 9():e39236. PubMed ID: 37494097
[TBL] [Abstract][Full Text] [Related]
15. Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System.
Hawkins EJ; Malte CA; Gordon AJ; Williams EC; Hagedorn HJ; Drexler K; Blanchard BE; Burden JL; Knoeppel J; Danner AN; Lott A; Liberto JG; Saxon AJ
JAMA Netw Open; 2021 Dec; 4(12):e2137238. PubMed ID: 34870679
[TBL] [Abstract][Full Text] [Related]
16. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
[TBL] [Abstract][Full Text] [Related]
17. Emergency department interventions for opioid use disorder: A synthesis of emerging models.
Thomas CP; Stewart MT; Tschampl C; Sennaar K; Schwartz D; Dey J
J Subst Abuse Treat; 2022 Oct; 141():108837. PubMed ID: 35841743
[TBL] [Abstract][Full Text] [Related]
18. Referral of patients from rural primary care clinics to telemedicine vendors for opioid use disorder treatment: A mixed-methods study.
Lin C; Zhu Y; Mooney LJ; Ober A; Clingan SE; Baldwin LM; Calhoun S; Hser YI
J Telemed Telecare; 2024 Jan; ():1357633X231226261. PubMed ID: 38258323
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR
Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331
[TBL] [Abstract][Full Text] [Related]
20. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
